Adam Binder

1.0k total citations
56 papers, 680 citations indexed

About

Adam Binder is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Adam Binder has authored 56 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 19 papers in Public Health, Environmental and Occupational Health and 16 papers in Hematology. Recurrent topics in Adam Binder's work include COVID-19 and healthcare impacts (8 papers), Neutropenia and Cancer Infections (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). Adam Binder is often cited by papers focused on COVID-19 and healthcare impacts (8 papers), Neutropenia and Cancer Infections (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). Adam Binder collaborates with scholars based in United States and Germany. Adam Binder's co-authors include Geoffrey R. Oxnard, Pasi A. Jänne, Joshua Brody, Linda Hammerich, Nathan Handley, Rachel E. Granberg, Arianna Heyer, Kristin L. Rising, Bernd Hamm and Matthias Taupitz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Frontiers in Immunology.

In The Last Decade

Adam Binder

46 papers receiving 673 citations

Peers

Adam Binder
Celeste Cagnazzo Italy
Kedar Kirtane United States
Christopher A. Smith United Kingdom
Garth Funston United Kingdom
Ming‐Mo Hou Taiwan
Nagashree Seetharamu United States
Stephanie Downs‐Canner United States
Ann K. Folkins United States
Allison Gockley United States
Celeste Cagnazzo Italy
Adam Binder
Citations per year, relative to Adam Binder Adam Binder (= 1×) peers Celeste Cagnazzo

Countries citing papers authored by Adam Binder

Since Specialization
Citations

This map shows the geographic impact of Adam Binder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Binder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Binder more than expected).

Fields of papers citing papers by Adam Binder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Binder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Binder. The network helps show where Adam Binder may publish in the future.

Co-authorship network of co-authors of Adam Binder

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Binder. A scholar is included among the top collaborators of Adam Binder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Binder. Adam Binder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Porcu, Pierluigi, et al.. (2025). PCV20 Improves Pneumococcal Vaccine Response in Myeloma Patients after Autologous Stem Cell Transplantation.. Transplantation and Cellular Therapy. 31(2). S370–S370. 1 indexed citations
2.
3.
Binder, Adam, et al.. (2025). Redefining central nervous system multiple myeloma: From rare phenomenon to emerging entity. Blood Reviews. 74. 101343–101343.
4.
Binder, Adam, Christopher J. Walker, Tomer M. Mark, & Muhamed Baljević. (2023). Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitors. Frontiers in Immunology. 14. 1275329–1275329. 14 indexed citations
5.
Kamaraju, Sailaja, et al.. (2023). Racial and Ethnic Differences in the Use of Electronic Medical Record Messaging Among Patients With Breast Cancer: A Quality Improvement Study. Clinical Breast Cancer. 23(7). e434–e440. 1 indexed citations
6.
Grosso, Dolores, Benjamin E. Leiby, Lindsay Wilde, et al.. (2022). A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation. Transplantation and Cellular Therapy. 28(12). 831.e1–831.e7. 3 indexed citations
7.
Sweeney, Ellen, Mercy George, Mary Harris, et al.. (2022). Implementation of an Outpatient HD-MTX Initiative. Frontiers in Oncology. 11. 773397–773397. 3 indexed citations
8.
Fernandez, Christian, Lydia Komarnicky, Sara E. Lally, et al.. (2022). High local control and low ocular toxicity using ultra-low-dose “boom-boom” radiotherapy for indolent orbital lymphoma. Chinese Clinical Oncology. 11(6). 44–44. 3 indexed citations
9.
Gergis, Usama, Joanne Filicko-O’Hara, John L. Wagner, et al.. (2021). The Two-Step Allogeneic Stem Cell Transplantation Approach Results in Rapid Engraftment and Excellent Outcomes in Patients with Lymphoid Malignancies. Transplantation and Cellular Therapy. 28(3). 159.e1–159.e5. 1 indexed citations
10.
Binder, Adam, et al.. (2021). COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study. Frontiers in Oncology. 11. 740320–740320. 4 indexed citations
11.
Ye, Xiangyun, et al.. (2020). Assessment of the Diagnostic Accuracy of Core Needle Biopsies in the Diagnosis of Lymphoma. Blood. 136(Supplement 1). 12–13. 2 indexed citations
12.
Binder, Adam, Nathan Handley, Lindsay Wilde, Neil Palmisiano, & Ana Mariá López. (2020). Treating Hematologic Malignancies During a Pandemic: Utilizing Telehealth and Digital Technology to Optimize Care. Frontiers in Oncology. 10. 1183–1183. 17 indexed citations
13.
14.
Wilde, Lindsay, et al.. (2020). Case Report: Tocilizumab for the Treatment of SARS-CoV-2 Infection in a Patient With Aplastic Anemia. Frontiers in Oncology. 10. 562625–562625. 2 indexed citations
15.
Grosso, Dolores, Matthew Carabasi, Joanne Filicko-O’Hara, et al.. (2020). Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on Outcomes. Biology of Blood and Marrow Transplantation. 26(10). 1861–1867. 3 indexed citations
16.
Bartash, Rachel, Kelsie Cowman, Wendy Szymczak, et al.. (2020). Multidisciplinary Tool Kit for Febrile Neutropenia: Stewardship Guidelines,Staphylococcus aureusEpidemiology, and Antibiotic Use Ratios. JCO Oncology Practice. 16(7). e563–e572. 2 indexed citations
17.
Steinberg, Amir, et al.. (2019). A Case of CCDC6-RET Fusion Mutation in Adult Acute Lymphoblastic Leukemia (ALL), a Known Activating Mutation Reported in ALL. Frontiers in Oncology. 9. 1303–1303. 4 indexed citations
18.
Alperovich, Anna, et al.. (2015). Composite angioimmunoblastic T-cell and diffuse large B-cell lymphoma. Hematology/Oncology and Stem Cell Therapy. 8(3). 136–137. 1 indexed citations
19.
Hammerich, Linda, Adam Binder, & Joshua Brody. (2015). In situ vaccination: Cancer immunotherapy both personalized and off‐the‐shelf. Molecular Oncology. 9(10). 1966–1981. 151 indexed citations
20.
Taupitz, Matthias, et al.. (1993). Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.. American Journal of Roentgenology. 161(1). 193–200. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Celeste Cagnazzo Breakdown of academic impact, for papers by Kedar Kirtane Breakdown of academic impact, for papers by Christopher A. Smith Breakdown of academic impact, for papers by Garth Funston Breakdown of academic impact, for papers by Ming‐Mo Hou Breakdown of academic impact, for papers by Nagashree Seetharamu Breakdown of academic impact, for papers by Stephanie Downs‐Canner Breakdown of academic impact, for papers by Ann K. Folkins Breakdown of academic impact, for papers by Allison Gockley
Rankless by CCL
2026